Biotech news on August 19, 2026

1. 0101:18 UTC

   Coverage recordKstp Television: “The Latest: Trump picks top White House aide Dr. Heidi Overton to lead FDA”

   7 outlets · first: STAT News Fda approval

   Reports ran between 01:18 and 20:15 UTC on Aug 19.

   The outlets that reported this event are listed with links to their reports; no summary of ours passed our automated checks for it, which says nothing about the event (how they work).

   Reported by STAT News, Kstp Television, iHeartRadio, nbcwashington.com, MedPage Today, Abc7news and Courant.

   • Food and Drug Administration
   • White House

2. 0207:00 UTC

   Coverage recordleadertelegram.com: “Mobile gold miners in eastern Congo complicate health worker efforts to contain Ebola”

   3 outlets · first: leadertelegram.com Pharma

   The outlets that reported this event are listed with links to their reports; no summary of ours passed our automated checks for it, which says nothing about the event (how they work).

   Reported by leadertelegram.com, ABC News and krmg.com.

   • Gold miners

3. 0309:30 UTC

   Patients and researchers challenge FDA-approved cancer drug dosages

   2 outlets · first: edition.cnn.com Fda approval

   Machine summary Patients and researchers are pushing for studies on lower or shorter dosing of cancer drugs, according to reports.

   1. The report states that physicians in Canada, Israel, Sweden, and additional nations had already been administering nivolumab and pembrolizumab at reduced doses, or over briefer spans, or with extended gaps, compared with what the FDA advised.

   Reported by edition.cnn.com and freerepublic.com.

4. 0402:00 UTC

   Antengene Debuts TriGager TCE and ATG-207 at 2nd Biotech Summit

   2 outlets · first: Pr Newswire Pharma Mostly press releases

   Machine summary Antengene is in the CLDN18.2 and TCE arenas.

   1. Antengene (SEHK: 6996.HK) announced it presented at the Evercore 2nd China Biotech Summit on August 18, 2026.
   2. The company claimed updated clinical data for ATG-022 (CLDN18.2 antibody-drug conjugate), but disclosed no efficacy or safety figures.
   3. TriGager TCE platform and multiple TCE functional modules were showcased for the first time, alongside the previously disclosed AnTenGager platform.
   4. Evercore hosted the summit; Antengene presented during a fireside chat.

   Reported by Pr Newswire and manilatimes.net.

   • Evercore
   • AnTenGager
   • Evercore 2nd China Biotech Summit
   • ATG-207
   • TriGager
   • ATG-022

Each summary and its key facts are a machine summary of the reports linked under it; the outlets, times and counts come from those reports' own records. How a rundown is built.